Tau PET pattern in corticobasal syndrome patients by using the 18F-AV-1451 positron emission tomography (PET)

Trial Profile

Tau PET pattern in corticobasal syndrome patients by using the 18F-AV-1451 positron emission tomography (PET)

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs Flortaucipir F 18 (Primary)
  • Indications Corticobasal degeneration
  • Focus Diagnostic use
  • Most Recent Events

    • 28 Aug 2017 New trial record
    • 16 Aug 2017 Results published in the Neurology
    • 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top